MDT

95.44

+0.22%↑

VEEV

294.39

+1.24%↑

A

142.08

+2.59%↑

HQY

92.37

-1.72%↓

TLRY

1.58

-1.25%↓

MDT

95.44

+0.22%↑

VEEV

294.39

+1.24%↑

A

142.08

+2.59%↑

HQY

92.37

-1.72%↓

TLRY

1.58

-1.25%↓

MDT

95.44

+0.22%↑

VEEV

294.39

+1.24%↑

A

142.08

+2.59%↑

HQY

92.37

-1.72%↓

TLRY

1.58

-1.25%↓

MDT

95.44

+0.22%↑

VEEV

294.39

+1.24%↑

A

142.08

+2.59%↑

HQY

92.37

-1.72%↓

TLRY

1.58

-1.25%↓

MDT

95.44

+0.22%↑

VEEV

294.39

+1.24%↑

A

142.08

+2.59%↑

HQY

92.37

-1.72%↓

TLRY

1.58

-1.25%↓

Search

Lyell Immunopharma Inc

Aperta

16.67 -3.92

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

16.54

Massimo

17.75

Metriche Chiave

By Trading Economics

Entrata

9.5M

-43M

Vendite

1K

8K

EPS

-2.89

Margine di Profitto

-533,550

Dipendenti

300

EBITDA

11M

-43M

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

-16.96% downside

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

120M

323M

Apertura precedente

20.59

Chiusura precedente

16.67

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bearish Evidence

Lyell Immunopharma Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

15 ott 2025, 23:25 UTC

I principali Market Mover

Salesforce Rises on New FY30 Financial Targets

15 ott 2025, 18:52 UTC

Utili
I principali Market Mover

Prologis Shares Gain on Raised Outlook, Data Center Growth

15 ott 2025, 18:30 UTC

Acquisizioni, Fusioni, Takeovers

Constellation Software to Buy U.K.'s Tecvia Holding

15 ott 2025, 17:19 UTC

Acquisizioni, Fusioni, Takeovers

Drahi's Altice Rejects $20 Billion Joint Offer From Peers -- 2nd Update

15 ott 2025, 17:11 UTC

Acquisizioni, Fusioni, Takeovers

Anglo American, MMG Offer Concessions to EU Merger Watchdog in Nickel Deal Probe

15 ott 2025, 23:48 UTC

Discorsi di Mercato

Gold Steady, Supported by Expectations of Ongoing Central Bank Purchases -- Market Talk

15 ott 2025, 23:38 UTC

Discorsi di Mercato

Nikkei May Rise, Tracking Gains Across Most U.S. Equity Markets -- Market Talk

15 ott 2025, 22:37 UTC

Discorsi di Mercato

Economic Stars Are Aligning for RBA -- Market Talk

15 ott 2025, 21:44 UTC

Utili

Stock Rally Is Lifting Wealth Managers. How Much Is Charles Schwab Benefiting? -- Barrons.com

15 ott 2025, 20:50 UTC

Discorsi di Mercato
Utili

Financial Services Roundup: Market Talk

15 ott 2025, 20:44 UTC

Acquisizioni, Fusioni, Takeovers

Restaurant Brands Recommends Hldrs Do Not Tender Their Shrs to the Offer >QSR.T

15 ott 2025, 20:44 UTC

Acquisizioni, Fusioni, Takeovers

Restaurant Brands Notified of Unsolicited Mini-Tender Offer to Buy Shrs at $28.80/Shr

15 ott 2025, 20:43 UTC

Acquisizioni, Fusioni, Takeovers

Restaurant Brands Notified of Unsolicited Mini-Tender Offer by NY Stk and Bond LLC to Purchase Up to 10,000 Common Shrs >QSR.T

15 ott 2025, 20:34 UTC

Utili

Prologis Raises Outlook as Warehouse Leasing Picks Up -- WSJ

15 ott 2025, 20:31 UTC

Acquisizioni, Fusioni, Takeovers

RBI Recommends Hldrs Reject NYSB's "Mini-Tender Offer"

15 ott 2025, 20:17 UTC

Acquisizioni, Fusioni, Takeovers

GE Vernova Stock Feill With Latest Call to Sell -- Barrons.com

15 ott 2025, 19:06 UTC

Utili

These Stocks Are Moving the Most Today: Bank of America, Morgan Stanley, ASML, AMD, Nvidia, Bunge, Progressive, Abbott, and More -- Barrons.com

15 ott 2025, 19:04 UTC

Discorsi di Mercato

Oil Futures Post Back-to-Back Losses -- Market Talk

15 ott 2025, 18:46 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Slip Ahead of Storage Data -- Market Talk

15 ott 2025, 18:23 UTC

Utili

This Insurer Is the One of the Worst Stocks in the S&P 500 Today. Here's Why. -- Barrons.com

15 ott 2025, 17:37 UTC

Acquisizioni, Fusioni, Takeovers

Constellation Software's Harris Operating Group Enters Into Agreement To Acquire TECVIA Holding GmbH >CSU.T

15 ott 2025, 17:34 UTC

Discorsi di Mercato

Oil Futures Lose Ground on Trade, Oversupply Concerns -- Market Talk

15 ott 2025, 16:57 UTC

Utili

The Nation's Biggest Banks Are Saying the Economy Is Still Strong -- WSJ

15 ott 2025, 16:51 UTC

Acquisizioni, Fusioni, Takeovers

EssilorLuxottica Doesn't Disclose Financial Details

15 ott 2025, 16:50 UTC

Acquisizioni, Fusioni, Takeovers

EssilorLuxottica: RetinAI Partners With Pharmaceutical Companies, Research Organizations

15 ott 2025, 16:49 UTC

Acquisizioni, Fusioni, Takeovers

EssilorLuxottica: Deal Reinforces the Group's Med-Tech Journey

15 ott 2025, 16:48 UTC

Acquisizioni, Fusioni, Takeovers

EssilorLuxottica: Ikerian Specializes in Artificial Intelligence, Data Management in Eyecare

15 ott 2025, 16:48 UTC

Acquisizioni, Fusioni, Takeovers

EssilorLuxottica: Ikerian Is a Health Technology Company, Operating Under the RetinAI Brand

15 ott 2025, 16:47 UTC

Acquisizioni, Fusioni, Takeovers

EssilorLuxottica Buys Ikerian

15 ott 2025, 16:34 UTC

Discorsi di Mercato

AMD Data Center Agreements Will Provide Big Revenue Growth -- Market Talk

Confronto tra pari

Modifica del prezzo

Lyell Immunopharma Inc Previsione

Obiettivo di Prezzo

By TipRanks

-16.96% in calo

Previsioni per 12 mesi

Media 14 USD  -16.96%

Alto 20 USD

Basso 10 USD

Basato su 3 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Lyell Immunopharma Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

3 ratings

1

Acquista

1

Mantieni

1

Vendi

Punteggio Tecnico

By Trading Central

0.4217 / 0.4691Supporto e resistenza

A breve termine

Strong Bearish Evidence

A termine intermedio

Weak Bearish Evidence

A lungo termine

No Evidence

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

help-icon Live chat